These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 34429113)
1. Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports. Hodkinson A; Heneghan C; Mahtani KR; Kontopantelis E; Panagioti M BMC Med; 2021 Aug; 19(1):195. PubMed ID: 34429113 [TBL] [Abstract][Full Text] [Related]
2. Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis. De Hert M; Yu W; Detraux J; Sweers K; van Winkel R; Correll CU CNS Drugs; 2012 Sep; 26(9):733-59. PubMed ID: 22900950 [TBL] [Abstract][Full Text] [Related]
4. Risperidone (depot) for schizophrenia. Sampson S; Hosalli P; Furtado VA; Davis JM Cochrane Database Syst Rev; 2016 Apr; 4(4):CD004161. PubMed ID: 27078222 [TBL] [Abstract][Full Text] [Related]
5. Retrospective Analysis of the Effectiveness and Tolerability of Long-Acting Paliperidone Palmitate Antipsychotic in Adolescent First-Episode Schizophrenia Patients. Petrić D; Rački V; Gačo N; Kaštelan A; Graovac M J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):197-204. PubMed ID: 30758986 [TBL] [Abstract][Full Text] [Related]
6. Quetiapine versus other atypical antipsychotics for schizophrenia. Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315 [TBL] [Abstract][Full Text] [Related]
7. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics. Maher AR; Theodore G J Manag Care Pharm; 2012 Jun; 18(5 Suppl B):S1-20. PubMed ID: 22784311 [TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
9. Intramuscular long-acting paliperidone palmitate in acute patients with schizophrenia unsuccessfully treated with oral antipsychotics. Hargarter L; Cherubin P; Bergmans P; Keim S; Rancans E; Bez Y; Parellada E; Carpiniello B; Vidailhet P; Schreiner A Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():1-7. PubMed ID: 25448776 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of paliperidone ER and other oral atypical antipsychotics in schizophrenia. Jones MP; Nicholl D; Trakas K Int J Clin Pharmacol Ther; 2010 Jun; 48(6):383-99. PubMed ID: 20497747 [TBL] [Abstract][Full Text] [Related]
11. Paliperidone ER and oral risperidone in patients with schizophrenia: a comparative database analysis. Turkoz I; Bossie CA; Lindenmayer JP; Schooler N; Canuso CM BMC Psychiatry; 2011 Feb; 11():21. PubMed ID: 21299844 [TBL] [Abstract][Full Text] [Related]
12. Acute Antipsychotic Treatment of Children and Adolescents With Schizophrenia-Spectrum Disorders: A Systematic Review and Network Meta-Analysis. Pagsberg AK; Tarp S; Glintborg D; Stenstrøm AD; Fink-Jensen A; Correll CU; Christensen R J Am Acad Child Adolesc Psychiatry; 2017 Mar; 56(3):191-202. PubMed ID: 28219485 [TBL] [Abstract][Full Text] [Related]
13. Paliperidone Palmitate 3-Monthly Versus 1-Monthly Injectable in Patients With Schizophrenia With or Without Prior Exposure to Oral Risperidone or Paliperidone: A Post Hoc, Subgroup Analysis. Mathews M; Pei H; Savitz A; Nuamah I; Hough D; Alphs L; Gopal S Clin Drug Investig; 2018 Aug; 38(8):695-702. PubMed ID: 29882073 [TBL] [Abstract][Full Text] [Related]
14. Healthcare resource utilization of second-generation long-acting injectable antipsychotics in schizophrenia: risperidone versus paliperidone palmitate. Joshi K; Pan X; Wang R; Yang E; Benson C Curr Med Res Opin; 2016 Nov; 32(11):1873-1881. PubMed ID: 27479694 [TBL] [Abstract][Full Text] [Related]
15. Paliperidone extended release: a review of its use in the management of schizophrenia. Chwieduk CM; Keating GM Drugs; 2010 Jul; 70(10):1295-317. PubMed ID: 20568835 [TBL] [Abstract][Full Text] [Related]